Trial Details

COMPLETED
Basic Information
Clinical ID c2964
Identifier NCT02727283
Trial Title A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Irritable Bowel Syndrome
Interventions DRUG: GSK3179106|DRUG: Placebo
Participant Information
Sponsor GlaxoSmithKline
City South Australia
Country/Region Australia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2015-11-26
Primary Completion Date 2016-03-18
Completion Date 2016-03-18